FDA extends J&J vaccine’s authorized shelf life
The Food and Drug Administration July 28 extended to six months the shelf life for Johnson & Johnson’s COVID-19 vaccine. The decision is based on data from ongoing stability assessment studies, which have demonstrated that the vaccine is stable at six months when refrigerated at temperatures of 36-46 degrees Fahrenheit (2-8 degrees Celsius). By extending the shelf life by an additional 45 days, the agency is preventing the looming expiration of millions of administered J&J doses. Vaccine providers are urged to visit J&J’s Expiry Checker website to confirm the latest expiration dates of the vaccine, including those currently available for administration throughout the U.S.
Related News Articles
Headline
The Centers for Disease Control and Prevention will update its immunization schedules for the COVID-19 and chickenpox vaccines to adopt recent recommendations…
Headline
The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial…
Headline
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…
Headline
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…
Headline
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…
Headline
COVID-19 infections are growing or likely growing in 45 states and not changing in five states, according to the latest data from the Centers for Disease…